Survivorship and the International Myeloma Foundation With Yelak Biru
Yelak Biru, President and CEO of the International Myeloma Foundation (IMF), joins the show to share his remarkable personal and professional journey. After imm
Yelak Biru, President and CEO of the International Myeloma Foundation (IMF), joins the show to share his remarkable personal and professional journey. After imm
The study showed a mortality risk reduction benefit in certain mutations while for others larger studies are needed.
Dr. Sanford shares unique experiences and insights on her life and career in this interview with GI Oncology Now.
A recent study explored the impact of common bladder cancer treatments on prevention, recurrence, and progression by introducing intra-arterial chemotherapy to existing treatment.
Allogeneic hematopoietic stem cell transplant for patients with blast phase myelofibrosis showed promising 3-year survival rates, according to research.
Heart attacks spike in the winter because the heart works harder to keep the body warm — and activities like shoveling snow can further strain…
Kirk R. Schultz, MD, FCAHS, a professor of pediatrics at the BC Children’s Hospital and Research Institute, discusses graft-versus-host disease updates at ASH 2024.
Rahul Banarjee: Excited to moderate the fiercest myeloma debate / Ajai Chari, Amrita Krishnan, Caitlin Costello, cancer, Hearn Jay Cho, Joshua Richter, Krina
Beyond being a dietary choice, veganism offers transformative benefits for personal health, environmental sustainability, and animal welfare. As the year winds down, it is natural…
Going vegan can be overwhelming at first, and many people deal with similar pitfalls. Find out how to fix the most common mistakes when cooking…